GNFT (Genfit S.A.) Kacepetan wutah bathi saben saham ing taun lumaku

Simbol resmi perusahaan genfit.com (GNFT)

The future pricing power of Genfit S.A. (GNFT) relies on the success of clinical trials in niche markets. The net income per share growth rate compared to last year confirms this trend, with the indicator holding at -720.00. Pipeline diversification across rare liver pathologies mitigates risks, while independence from macroeconomic factors transforms the asset into a reliable defensive tool.

GNFT (Genfit SA) riwayat Wutah bathi ing taun lumaku saka 04.07.2022 nganti 06.12.2025

Rincian analitis lan laporan data perusahaan Genfit S.A. (GNFT)

- rega saham lan konsensus proyeksi valuasi:
- indikator valuasi pasar bisnis:
Pambiji fundamental:Genfit S.A. GNFT
Produk mawa merek Genfit Corp

This indicator measures the annual dynamics of net profit per share, reflecting management's ability to generate income per ownership stake. By analyzing the annual variation in EPS, an investor can discern capital sensitivity to operational shocks, which is critical for Genfit S.A. (GNFT) due to liquidity shortages and the uncertain outcomes of clinical trials for liver pathology drugs.